Principal Financial Group Inc. Has $290.20 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Principal Financial Group Inc. trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 0.5% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 585,936 shares of the medical equipment provider's stock after selling 2,727 shares during the quarter. Principal Financial Group Inc. owned approximately 0.16% of Intuitive Surgical worth $290,197,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also made changes to their positions in the company. Oregon Public Employees Retirement Fund grew its stake in Intuitive Surgical by 0.5% during the 1st quarter. Oregon Public Employees Retirement Fund now owns 30,671 shares of the medical equipment provider's stock worth $15,190,000 after buying an additional 151 shares during the last quarter. Clarity Capital Partners LLC lifted its holdings in shares of Intuitive Surgical by 0.7% in the first quarter. Clarity Capital Partners LLC now owns 5,815 shares of the medical equipment provider's stock valued at $2,880,000 after buying an additional 43 shares during the period. Resonant Capital Advisors LLC lifted its holdings in shares of Intuitive Surgical by 1.4% in the first quarter. Resonant Capital Advisors LLC now owns 1,554 shares of the medical equipment provider's stock valued at $770,000 after buying an additional 22 shares during the period. Teacher Retirement System of Texas lifted its holdings in shares of Intuitive Surgical by 6.3% in the first quarter. Teacher Retirement System of Texas now owns 189,749 shares of the medical equipment provider's stock valued at $93,977,000 after buying an additional 11,245 shares during the period. Finally, Novem Group acquired a new stake in shares of Intuitive Surgical during the first quarter worth $388,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Up 0.6%

Shares of ISRG traded up $3.14 during midday trading on Friday, reaching $543.74. 704,815 shares of the stock were exchanged, compared to its average volume of 1,672,707. Intuitive Surgical, Inc. has a 12-month low of $413.82 and a 12-month high of $616.00. The firm has a 50 day simple moving average of $537.11 and a 200-day simple moving average of $536.83. The company has a market cap of $194.89 billion, a price-to-earnings ratio of 79.73, a P/E/G ratio of 5.78 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. The company had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same period last year, the business earned $1.50 EPS. Research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Transactions at Intuitive Surgical

In related news, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the transaction, the senior vice president directly owned 907 shares of the company's stock, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Gary Loeb sold 1,700 shares of the firm's stock in a transaction that occurred on Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the transaction, the executive vice president directly owned 2,245 shares in the company, valued at $1,152,089.10. The trade was a 43.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 4,998 shares of company stock valued at $2,611,577 over the last 90 days. Company insiders own 0.70% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on ISRG shares. Royal Bank Of Canada cut their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft lowered Intuitive Surgical from a "hold" rating to a "sell" rating and cut their target price for the stock from $515.00 to $440.00 in a research report on Monday, June 9th. Evercore ISI cut their target price on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research report on Wednesday, April 23rd. Erste Group Bank raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Thursday, June 5th. Finally, Robert W. Baird cut their target price on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $588.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.